Novavax Presents COVID-19 Booster and Flu Combo Vaccine Studies

At the World Vaccine Congress in Washington, D.C. on Wednesday, Maryland-based Novavax presented data on its COVID-19 booster and COVID-influenza combination vaccine candidate. Novavax shares rose 12% Thursday following the presentation.